HomeBusinessVivek Ramaswamy's Net Worth Is 9 Figures – See How The DOGE...

Vivek Ramaswamy’s Net Worth Is 9 Figures – See How The DOGE Co-Leader Made His Millions

Chip Somodevilla/Getty Images

  • According to former Republican presidential candidate, entrepreneur and author Vivek Ramaswamy, he has a net worth of $800 million. Net Worth of Celebrities.

  • Most of Ramaswamy’s wealth comes from his 10% stake in Roivant Sciences, a pharmaceutical company he founded.

  • He also co-founded investment firm Strive Asset Management, in which he has a stake of more than $100 million.

  • Ramaswamy was recently appointed as co-leader of President-elect Trump’s new Department of Government Efficiency, along with Tesla CEO Elon Musk.

Former Republican presidential candidate, entrepreneur and author Vivek Ramaswamy is almost a billionaire, thanks to his investments in biotech and financial companies.

According to Ramaswamy, he has an estimated net worth of $800 million Net Worth of Celebrities. Ramaswamy was recently appointed as co-leader of President-elect Trump’s new Department of Government Efficiency, along with Tesla CEO Elon Musk.

From founding his own biotech and financial companies to his stake in private jets, this is how Ramaswamy made his millions.

Most of Ramaswamy’s wealth comes from his stake in Roivant Sciences, a pharmaceutical company he founded in 2014. Roivant has subsidiaries that develop drugs and technologies to treat various medical conditions, including psoriasis and cancer.

In 2020, Japanese pharmaceutical company Sumitomo Dainippon bought ownership stakes in five of Roivant’s companies for $3 billion and a 10% stake in Roivant. Ramaswamy reported more than $176 million in total income that year, including $174 million in capital gains.

Roivant went public in 2021 at a valuation of $7.3 billion and has a market capitalization of $8.2 billion at the time of writing. According to Ramaswamy, he owns about 10% of Roivant Forbes. Ramaswamy stepped down as CEO of Roivant in 2021, but remained chairman until 2023, when he left to focus on his presidential campaign. The Ohio native sold $33 million worth of shares in Roivant in January 2024 to fund his largely self-funded presidential campaign. Bloomberg.

One of Roivant’s subsidiaries, Axovant, went public in 2015 at a valuation of $2.2 billion – the largest US biotech IPO at the time. Ramaswamy reported $37 million in capital gains on his tax returns that year, with total income of almost $39 million.

Before founding Roivant Sciences, Ramaswamy worked at QVT Financial, where he managed the company’s biotech portfolio and earned $7 million in total compensation between 2007 and 2014.

See also  The 2025 tax brackets are here. How much do you owe?
- Advertisement -
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments